Healthcare - Medical - Diagnostics & Research - NASDAQ - CN
$ 3.75
1.35 %
$ 36.3 M
Market Cap
-0.49
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
117.94%
EBIT
Estimate
--53.48%
Net Income
Estimate
58.56%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Burning Rock Biotech Limited
BNR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BNR
EBIT FORECAST
EBIT Forecast Chart BNR
NET INCOME FORECAST
Net Income Chart BNR